Expression of transforming growth factor beta (TGF-b1) by human preterm lung inflammatory cells

Life Sciences

Volumn 79, Issue 25, 2006, Pages 2349-2356

  Kwong, K Y ^a   Niang, S ^a   Literat, A ^a   Zhu, N L ^a   Ramanathan, R ^a   Jones, C A ^a   Minoo, P ^a  

^a LAC USC MEDICAL CENTER   (United States)

Author keywords

Bronchopulmonary dysplasia; Inflammation; Lipopolysaccharide; Lung; Premature; Transforming growth factor beta 1

Indexed keywords

LIPOPOLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFANT; LUNG ALVEOLUS CELL; LUNG DYSPLASIA; LUNG LAVAGE; MACROPHAGE; NEUTROPHIL; NEWBORN; PREMATURITY; PROTEIN EXPRESSION; RESPIRATORY DISTRESS; RESPIRATORY TRACT INTUBATION;

BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOPULMONARY DYSPLASIA; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFANT, NEWBORN; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES; NEUTROPHILS; PREGNANCY; PREMATURE BIRTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33751120956     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.07.040     Document Type: Article

References (40)

1. Bancalari E. Corticosteroids and neonatal chronic lung disease. European Journal of Pediatrics 157 Suppl 1 (1998) S31-S37 Review
2. Bellocq A., Azoulay E., Marullo S., Flahault A., Fouqueray B., Philippe C., Cadranel J., and Baud. Reactive oxygen and nitrogen intermediates increase transforming growth factor-b1 release from human epithelial alveolar cells through two different mechanisms. American Journal of Respiratory and Cellular Molecular Biology 21 (1999) 128-136
3. Buckley S., Bui K.C., and Wharburton D. Dynamics of TGF-beta 3 peptide activity during rat alveolar epithelial cell proliferative recovery from acute hyperoxia. American Journal of Physiology 271 1Pt1 (1996) L54-L60
4. Chao C.C., Hu S., Sheng W.S., Tsang M., and Peterson P.K. Tumor necrosis factor-alpha mediates the release of bioactive transforming-beta in murine microglial cell culture. Clinical Immunology and Immunopathology 77 3 (1995) 358-365
5. Chu H.W., Trudeau J.B., Balzar S., and Wenzel S.E. Peripheral blood and airway tissue expression of transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects. Journal of Allergy and Clinical Immunology 106 6 (2000) 1115-1123
6. Coker R.K., Laurent G.J., Jeffrey P.K., du Bois R.M., Black C.M., and McAnulty R.J. Localization of transforming growth factor B1 and B3 mRNA transcripts in normal and fibrotic human lung. Thorax 56 7 (2001) 549-556
7. Durand M., Mendoza M.E., Tantivit P., Kugelman A., and McEvoy C. A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation. Pediatrics 109 2 (2002) 262-268
8. Elias J.A., Zheng T., Lee C.G., Homer R.J., Chen Q., Ma B., Blackburn M., and Zhu Z. Transgenic modeling of interleukin-13 in the lung. Chest 123 3 Suppl (2003) 339S-345S
9. Giri D., and Ittmann M. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia. American Journal of Pathology 159 1 (2001) 139-147
10. Hancock A., Armstrong L., Gama R., and Millar A. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. American Journal of Respiratory and Cellular Molecular Biology 18 1 (1998) 60-65
11. Holgate S.T., Lackie P., Wilson S., Roche W., and Davies D. Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma. American Journal of Respiratory and Critical Care Medicine 162 3 Pt 2 (2000) S113-S117
12. Holgate S.T., Lackie P.M., Howarth P.H., Roche W.R., Puddicombe S.M., Richter A., Wilson S.J., Holloway J.W., and Davies D.E. Invited lecture: activation of the epithelial mesenchymal trophic unit in the pathogenesis of asthma. International Archives of Allergy and Immunology 124 1-3 (2001) 253-258
13. Hoshino M., Takahashi M., and Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. Journal of Allergy and Clinical Immunology 107 2 (2001) 295-301
14. Jankov R.P., and Transwell A.K. Growth factors, postnatal lung growth and bronchopulmonary dysplasia. Pediatr. Resp. Rev. vol. 5 (A) (2004) S265-S275
15. Jeffery P. Inflammation and remodeling in the adult and child with asthma. Pediatric Pulmonology. Supplement 21 (2001) 3-16 Review
16. Johnson P.R., Black J.L., Carlin S., Ge Q., and Underwood P.A. The production of extracellular matrix proteins by human passively sensitized airway smooth-muscle cells in culture: the effect of beclomethasone. American Journal of Respiratory and Critical Care Medicine 162 6 (2000) 2145-2151
17. Jones C.A., Cayabyab R.G., Kwong K.Y., Stotts C., Wong B., Hamdan H., Minoo P., and deLemos R.A. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatric Research 39 6 (1996) 966-975
18. Kwong K.Y., Jones C.A., Cayabyab R., Lecart C., Stotts C.L., Randhawa I., Ramanathan R., Khuu N., Minoo P., and deLemos R.A. Differential regulation of IL-8 by IL-1beta and TNF-alpha in hyaline membrane disease. Journal of Clinical Immunology 18 1 (1998) 71-80
19. Kwong K.Y., Literat A., Zhu N.L., Huang H.H., Li C., Jones C.A., and Minoo P. Expression of transforming growth factor beta (TGF-b1) in human epithelial alveolar cells: a pro-inflammatory mediator independent pathway. Life Sciences 74 (2004) 2941-2957
20. Lasky J.A., and Ortiz L.A. Antifibrotic therapy for the treatment of pulmonary fibrosis. American Journal of the Medical Sciences 322 4 (2001) 213-221 Review
21. Lecart C., Cayabyab R., Buckley S., Morrison J., Kwong K.Y., Warburton D., Ramanathan, Jones C.A., and Minoo P. Bioactive transforming growth factor-beta in the lungs of extremely low birthweight neonates predicts the need for home oxygen supplementation. Biology of the Neonate 77 4 (2000) 217-223
22. Lee C.G., Homer R.J., Zhu Z., Lanone S., Wang X., Koteliansky V., Shipley J.M., Gotwals P., Noble P., l Chen Q., Senior R.M., and Elias J.A. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). Journal of Experimental Medicine 194 6 (2001) 809-821
23. Li C.Y., and Baek J.Y. Mastocytosis and fibrosis: role of cytokines. International Archives of Allergy and Immunology 127 2 (2002) 123-126
24. Liu J.Y., and Brody A.R. Increased TGF-beta1 in the lungs of asbestos-exposed rats and mice: reduced expression in TNF-alpha receptor knockout mice. Journal of Environmental Pathology, Toxicology and Oncology 20 20 (2001) 97-108
25. Ohkawara Y., Tamura G., Iwasaki T., Tanaka A., Kikuchi T., and Shirato K. Activation and transforming growth factor-beta production in eosinophils by hyaluronan. American Journal of Respiratory and Cellular Molecular Biology 3 4 (2000) 444-451
26. Ortiz L.A., Lasky J., Hamilton Jr. R.F., Holian A., Hoyle G.W., Banks W., Peschon J.J., Brody A.R., Lungarella G., and Friedman M. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. Experimental Lung Research 24 6 (1998) 721-743
27. Rameshwar P., Narayanan R., Qian J., Denny T.N., Colon C., and Gascon P. NF-Kb as a central mediator in the induction of TGF-b in monocytes from patients with idiopathic myelofibrosis: An inflammatory response beyond the realm of homeostasis. Journal of Immunology 165 (2000) 2271-2277
28. Rimensberger P.C. Neonatal respiratory failure. Current Opinions in Pediatrics 14 3 (2002) 315-321
29. Sheppard D. Integrin-mediated activation of transforming growth factor-beta(1) in pulmonary fibrosis. Chest 120 1 Suppl (2001) 49S-53S
30. Speer C.P. Inflammation and bronchopulmonary dysplasia. Seminars in Neonatology 8 1 (2003) 29-38
31. Strieter R.M. Mechanisms of pulmonary fibrosis: conference summary. Chest 120 1 Suppl (2001) 77S-85S
32. Taipale J., Lohi J., Saarinen, Kovanen P.T., and Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta from the extracellular matrix of cultured human epithelial and endothelial cells. Journal of Biologic Chemistry 270 9 (1995) 4689-4696
33. Toossi Z., Hirsch C.S., Hamilton B.D., Knuth C.K., Friedlander M.A., and Rich E.A. Decreased production of TGF-beta 1 by human alveolar macrophages compared with blood monocytes. Journal of Immunology 156 9 (1996) 3461-3468
34. Toti P., Buonocore G., Tanganelli P., Catella A.M., Palmeri M.L., Vatti R., and Seemayer T.A. Bronchopulmonary dysplasia of the premature baby: an immunohistochemical study. Pediatric Pulmonology 24 1 (1997) 22-28
35. Vanacker N.J., Palmans E., Kips J.C., and Pauwels R.A. Fluticasone inhibits but does not reverse allergen-induced structural airway changes. American Journal of Respiratory and Critical Care Medicine 163 3 Pt 1 (2001) 674-679
36. Vento G., Matassa P.G., Ameglio F., Capoluongo E., Tortorolo L., and Romangnoli C. Effects of early dexamethasone therapy on pulmonary fibrogenic mediators and respiratory mechanics in premature infants. European Cytokine Network 13 2 (2002) 207-214
37. Vento G., Matassa P.G., Ameglio F., Capouongo E., Tortotolo L., and Romagnoli C. Effects of early dexamethasone therapy on pulmonary fibrogenic mediators and respiratory mechanics in preterm infants. European Cytokine Network 13 2 (2002) 207-214
38. Warburton D., Bellusci S., De Langhe S., Del Moral P.M., Fleury V., Mallieux A., Tefft D., Unbekandt M., Wang K., and Shi W. Molecular mechanisms of early lung specification and branching morphogenesis. Pediatric Research 57 5Pt2 (2005) 26R-37R Epub 2005 Apr 6
39. Warshamana G.S., Corti M., and Brody A.R. TNF-alpha, PDGF, and TGF-beta(1) expression by primary mouse bronchiolar-alveolar epithelial and mesenchymal cells: tnf-alpha induces TGF-beta(1). Experimental Molecular Pathology 71 1 (2001) 13-33
40. Zhou Z., Homer R.J., Wang Z., Qingsheng C., Geba G.P., Wang J., Zang Y., and Elias J.A. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities and eotaxin production. Journal of Clinical Investigation 103 (1999) 779-788